Hemangioma medical therapy

Hemangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemangioma medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemangioma medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemangioma medical therapy
CDC on Hemangioma medical therapy
Hemangioma medical therapy in the news
Blogs on Hemangioma medical therapy
Directions to Hospitals Treating Hemangioma
Risk calculators and risk factors for Hemangioma medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical therapy

• Most hemangiomas disappear without treatment, leaving minimal or no visible marks.

• Large hemangiomas can leave visible skin changes secondary to severe stretching of the skin or damage to surface texture.

• When hemangiomas interfere with vision, breathing, or threaten significant cosmetic injury, they are usually treated.

• The mainstay of treatment is oral corticosteroid therapy. Other drugs such as interferon or vincristine are sometimes considered if the corticosteroids do not work.

References

Template:WikiDoc Sources